Biotech Diaries - May 9th, 2024 (feat. Claudia Andretta)

Did you miss last week's newsletter? ??

Check out the edition from May 1st if you haven't seen it yet!

Topics included:

?? iPS cells are a go-to cell model ??

?? Podcast episode of SalesDNA: Decoding life science sales ??

?? ASGCT is right around the corner ??

?? Life science career coaching poll ???

?? SK pharmteco to manufacture groundbreaking gene therapy ??

?? Guest post from David Bruehlmann ??

Here's the link: linkedin.com/pulse/biotech-diaries-may-1st-2024-feat-david-br%25C3%25BChlmann-bissen--jhble

Now for this week's newsletter!

2 companies focused on iPSCs ??

Induced pluripotent stem cells (iPSCs) are powerful tools, both for drug discovery and for cell therapy.

Originally called Pluriomics, Ncardia was formed in 2011 to offer iPSC-derived products (and also services now!) for research applications.

Then, in 2022, Cellistic was launched as Ncardia's allogeneic cell therapy manufacturing brand.

Learn more about each company here: linkedin.com/posts/jeffbissen_drugdiscovery-celltherapy-biotechdiaries-activity-7190685972462796800-7Ym_

LinkedIn as a tool for career acceleration ??

This platform is a fantastic tool for creating and fostering professional connections - from scientists looking to promote their latest research, to CEOs looking to spread the word about their disruptive technology.

From my own experience in biotech, I can personally attest to the results of personal branding on LinkedIn .

I even had the chance to speak about this and other aspect of my career journey on the SalesDNA podcast with Harrison Waid and Nicholas Clare from Succession , a sales training company specialized in life sciences.

Check it out here: linkedin.com/posts/jeffbissen_sales-marketing-biotechdiaries-activity-7191053468176969730-SwTx

2 posters at ASGCT ??

The annual meeting of the American Society of Gene & Cell Therapy is happening right now!

Ncardia has a booth and is presenting 2 posters.

Focused on CGT applications, we're highlighting how iPSCs can be used for AAV development.

See the details here: linkedin.com/posts/jeffbissen_genetherapy-celltherapy-biotechdiaries-activity-7191781837172625409-0g-X

Biotech career goal poll ?

I posted a poll asking if my life science connections would be interested in career coaching.

And there's a ton of interest!

I'm not too surprised to see these results because lots of people want successful careers in industry, but they don't know how because universities tend to focus on advice for careers in academia.

Check out the full results here: linkedin.com/posts/jeffbissen_biotechnology-academia-careergoals-activity-7192140865513947136-tCDj

This week's guest post: Claudia Andretta ??

Do you know about #MergersMondays from Claudia Andretta?

As you might guess from the hashtag, she posts each Monday about mergers and acquisitions in the biotech industry.

This week, she talks about Harmony Biosciences ' acquisition of Epygenics Therapeutics and 诺华 ' acquisition of Mariana Oncology .

See more here, and follow her for weekly updates: linkedin.com/posts/andrettaclaudia_mergersmonday-mergersmonday-biopharma-activity-7193318616426033152-FCWb

Subscribe for more life science insights ??

Hi, I'm Jeff Bissen (pronounced BEE-sen), and I have 10 years of biotech experience - first in research and now on the business side of the industry.

Did you enjoy this newsletter?

Click the blue "Subscribe" button below, and share it with your colleagues!

Biotech Diaries is a weekly roundup of my journey as a life science professional, plus guest posts from industry leaders.